We are interested in studying individuals with GATAD2A variants to further characterize the genotype-phenotype relationships. Our strategies continued clinical phenotyping of GARND by retrospective analysis of medical records, MRI and EEGs along with parental interviews. We will also continue to use of various mouse and human stem cell models, to characterize the clinical and molecular consequences of GATAD2A variants.
GATAD2A